DE60100666D1 - Tierärztliche zusammensetzungen zur behandlung von parasiterkrankungen - Google Patents

Tierärztliche zusammensetzungen zur behandlung von parasiterkrankungen

Info

Publication number
DE60100666D1
DE60100666D1 DE60100666T DE60100666T DE60100666D1 DE 60100666 D1 DE60100666 D1 DE 60100666D1 DE 60100666 T DE60100666 T DE 60100666T DE 60100666 T DE60100666 T DE 60100666T DE 60100666 D1 DE60100666 D1 DE 60100666D1
Authority
DE
Germany
Prior art keywords
diseases
parasital
treating
veterinary compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60100666T
Other languages
English (en)
Other versions
DE60100666T2 (de
Inventor
A Abdul Rahman Shoa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEW PHARMA RES SWEDEN LUND AB
Original Assignee
NEW PHARMA RES SWEDEN LUND AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEW PHARMA RES SWEDEN LUND AB filed Critical NEW PHARMA RES SWEDEN LUND AB
Application granted granted Critical
Publication of DE60100666D1 publication Critical patent/DE60100666D1/de
Publication of DE60100666T2 publication Critical patent/DE60100666T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60100666T 2000-02-29 2001-02-22 Tierärztliche zusammensetzungen zur behandlung von parasiterkrankungen Expired - Lifetime DE60100666T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00104126A EP1129713A1 (de) 2000-02-29 2000-02-29 Tierärztliche Zusammensetzungen zur Behandlung von Parasiterkrankungen
EP00104126 2000-02-29
PCT/EP2001/002037 WO2001064222A1 (en) 2000-02-29 2001-02-22 Veterinary compositions for the treatment of parasitic diseases

Publications (2)

Publication Number Publication Date
DE60100666D1 true DE60100666D1 (de) 2003-10-02
DE60100666T2 DE60100666T2 (de) 2004-06-24

Family

ID=8167975

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60100666T Expired - Lifetime DE60100666T2 (de) 2000-02-29 2001-02-22 Tierärztliche zusammensetzungen zur behandlung von parasiterkrankungen

Country Status (11)

Country Link
US (2) US6777448B2 (de)
EP (2) EP1129713A1 (de)
CN (1) CN1213756C (de)
AT (1) ATE247970T1 (de)
AU (2) AU3548901A (de)
BR (1) BR0108727A (de)
DE (1) DE60100666T2 (de)
ES (1) ES2206406T3 (de)
NZ (1) NZ521533A (de)
TR (1) TR200302027T4 (de)
WO (1) WO2001064222A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
KR20050103685A (ko) * 2004-04-27 2005-11-01 삼성전자주식회사 액정 표시 장치용 휘도 강화 필름 및 그 제조 방법
GB0711957D0 (en) * 2007-06-21 2007-08-01 Syntopix Ltd Formulations
DE102010051404B4 (de) 2010-11-16 2017-08-31 Marc de Cocq Verwendung von substituierten Salicylaniliden zur Behandlung von Fischen
RU2569740C1 (ru) * 2014-05-20 2015-11-27 Рамзия Тимергалеевна Маннапова Способ коррекции минерального обмена при диктиокаулезе овец
CN104800158A (zh) * 2015-04-14 2015-07-29 四川美嘉龙生物科技有限公司 一种碘醚柳胺制剂及制备方法
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL184257C (nl) * 1974-06-19 1989-06-01 Merck & Co Inc Werkwijze voor het bereiden van rafoxanide preparaten.
US4128632A (en) * 1978-02-13 1978-12-05 Merck & Co., Inc. Solubilization of Rafoxanide
AU527154B2 (en) * 1978-12-15 1983-02-17 Pitman-Moore Australia Limited Composition and process
ZA842571B (en) 1983-04-07 1985-11-27 Merck & Co Inc Novel synergistic antiparasitic combinations
IE58016B1 (en) * 1983-08-12 1993-06-16 Ici Australia Ltd Pour-on formulation for the control of parasites
NZ209100A (en) * 1983-08-22 1987-01-23 Ici Australia Ltd Topical compositions for control of endoparasites
AU5733986A (en) * 1985-05-13 1986-11-20 Syntex (U.S.A.) Inc. Anthelmintic compositions comprising a benzimidazole derivative and the fasciolicide rafoxanide
US5340804A (en) * 1991-11-14 1994-08-23 Eli Lilly And Company 1,5-diphenyl-3-formazancarbonitril parasiticides
WO1995016447A1 (en) * 1993-12-13 1995-06-22 Michael Hilary Burke Anthelmintic composition containing rafoxanide and fenbendazole
EP1137627A1 (de) 1998-12-10 2001-10-04 Bayer Aktiengesellschaft Verfahren zur herstellung von zwischenprodukten für die strobilurin synthese

Also Published As

Publication number Publication date
TR200302027T4 (tr) 2004-01-21
WO2001064222A1 (en) 2001-09-07
DE60100666T2 (de) 2004-06-24
CN1406130A (zh) 2003-03-26
EP1129713A1 (de) 2001-09-05
US20040072909A1 (en) 2004-04-15
NZ521533A (en) 2003-03-28
EP1259244A1 (de) 2002-11-27
AU3548901A (en) 2001-09-12
EP1259244B1 (de) 2003-08-27
US6777448B2 (en) 2004-08-17
US20030049309A1 (en) 2003-03-13
ATE247970T1 (de) 2003-09-15
AU2001235489B2 (en) 2004-11-18
BR0108727A (pt) 2002-11-05
ES2206406T3 (es) 2004-05-16
CN1213756C (zh) 2005-08-10

Similar Documents

Publication Publication Date Title
ATE355075T1 (de) Behandlung der glykogenspeicherkrankheit typ ii
MY118356A (en) Antiparasitic composition for the treatment and protection of pets.
DK1133316T3 (da) Adenovirus-formulering til genterapi
IL208697A0 (en) Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
RU94046143A (ru) Фармацевтическая композиция для лечения глаукомы
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
DK0722313T3 (da) Viskoelastiske sammensætninger af fluorerede organiske forbindelser
BRPI0418115A (pt) formulação lìquida estável de hormÈnio de crescimento
BRPI0415906A (pt) formulão inseticida
DE60100666D1 (de) Tierärztliche zusammensetzungen zur behandlung von parasiterkrankungen
PE20040324A1 (es) Formulaciones liquidas de baja dosis de entecavir y uso
EE05124B1 (et) Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine
ATE290400T1 (de) Zusammensetzung zur behandlung von degenerativen gelenkerkrankungen
DE69103773D1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
NO20081754L (no) Anthelmintiske formuleringer
DE60135845D1 (de) Pralmorelin-haltige nasentropfen-präparate
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
ES2286949A1 (es) Uso de combinaciones de peroxido de metil etil cetona por pulverizacion.
ES2102370T3 (es) Composicion antiparasitaria para uso animal.
AR034835A1 (es) Composicion micelar para el tratamiento de enfermedades parasitarias en animales y uso de dicha composicion.
JO2214B1 (en) Veterinary formulations to treat parasitic diseases
RU2002126632A (ru) Водная лекарственная композиция для лечения заболеваний кожи
BR0215498A (pt) Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes
TH71075A (th) องค์ประกอบของสารให้ความหอมเทอร์ปีนอยด์ที่ทำให้เสถียรด้วยเกลือของกรดมาโลนิก
RU2003116018A (ru) Препарат "фуракол" для лечения эндометритов у животных

Legal Events

Date Code Title Description
8364 No opposition during term of opposition